This study elucidated potential novel therapeutic options for sepsis therapy, as it was demonstrated that the deteriorating AQP5 mRNA expression [7] in immune cells can be downregulated by the sulfonamide methazolamide and it is also capable of reducing immune cell migration. Here, AQP5 is linked to Sepsis.